Granules logo. Photo: https://granulesindia.com/
Granules is recalling more than 33,000 bottles of hypertension drug Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, in the U.S. market.
It is a voluntary, firm-initiated recall on account of failed dissolution specifications. The product failed to meet dissolution acceptance criteria in the stability studies at the 6th month, the U.S. Food and Drug Administration (U.S. FDA) said in its latest enforcement report.
Granules Pharmaceuticals Inc is recalling 27,648 100-count bottles and 5,376 500-count bottles of the drug manufactured by Granules India, Hyderabad.
Published – July 09, 2025 09:00 pm IST
#Granules #recalling #bottles #hypertension #drug #U.S
Granules recalling hypertension drug in U.S.,Granules hypertension drug Metoprolol Succinate Extended-Release Tablets,FDA enforcement report on Granules hypertension drug
latest news today, news today, breaking news, latest news today, english news, internet news, top news, oxbig, oxbig news, oxbig news network, oxbig news today, news by oxbig, oxbig media, oxbig network, oxbig news media
HINDI NEWS
News Source